Legacy Financial Group (Iowa)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-95
Closed -$2.65K 60
2023
Q3
$2.65K Buy
+95
New +$3.11K ﹤0.01% 445

Other funds holding ARKG

Legacy Financial Group (Iowa)'s ARKG Position: Q4 2023 in Review

Legacy Financial Group (Iowa) sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 95 shares — an estimated $2.65K sold.

Legacy Financial Group (Iowa) first reported a position in ARKG in Q3 2023 and held it in 1 quarter. The position peaked at $2.65K in Q3 2023. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • Legacy Financial Group (Iowa) reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • Legacy Financial Group (Iowa) sold 95 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $2.65K.
  • Legacy Financial Group (Iowa) first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 1 quarter.
  • Legacy Financial Group (Iowa)'s ARK Genomic Revolution ETF position peaked at $2.65K in Q3 2023.
  • 298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Legacy Financial Group (Iowa)'s 13F filing for Q4 2023, filed 22 Jan 2024.